Kostia Janssens
Corporate Officer/Principal en Epitopoietic Research Corp. .
Cargos activos de Kostia Janssens
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Epitopoietic Research Corp.
 Epitopoietic Research Corp. BiotechnologyHealth Technology Part of ERC-Belgium SA, Epitopoietic Research Corp. is a clinical stage emerging bio-pharmaceutical company based in Pasadena, CA. The company is developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with glioblastoma multiforme (GBM), the most deadliest form of brain cancer, using its patented Gliovac/ERC1671 vaccine. The company was founded by Bernard Alliaume, Apostolos Stathopoulos. Apostolos Stathopoulos has been the CEO since incorporation. | Corporate Officer/Principal | - | - |
Historial de carrera de Kostia Janssens
Estadísticas
Internacional
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Epitopoietic Research Corp.
Epitopoietic Research Corp. BiotechnologyHealth Technology Part of ERC-Belgium SA, Epitopoietic Research Corp. is a clinical stage emerging bio-pharmaceutical company based in Pasadena, CA. The company is developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with glioblastoma multiforme (GBM), the most deadliest form of brain cancer, using its patented Gliovac/ERC1671 vaccine. The company was founded by Bernard Alliaume, Apostolos Stathopoulos. Apostolos Stathopoulos has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Kostia Janssens
- Experiencia
